Pharmaceuticals Related News

Isogenica Announces New Licence Agreement with Maverick Therapeutics

CAMBRIDGE, England--(BUSINESS WIRE)--Isogenica Ltd, a leader in the design and construction of innovative and highly diverse synthetic antibody libraries, today announced a new licensing deal with Maverick Therapeutics, a private start-up biotechnology company utilising a proprietary T-cell engagement format for [...]

By | February 7th, 2017|BioPharma & Healthcare, News, Pharmaceuticals, Press Releases|

Meet the Speakers: Will Synthetic Biology be the Key to Our Future Health?

SynBioBeta’s fifth annual London conference is fast approaching, with leaders in industry, academia, and investment once again set to converge on Imperial College London between April 4th and 6th. A full schedule of exciting events and sessions has been lined [...]

By | February 1st, 2017|BioPharma & Healthcare, News, Pharmaceuticals, Therapeutics|

Bactevo Wins Innovate Award

Cambridge UK, 25th January 2017 – Bactevo, the revolutionary Cambridge, UK-based drug discovery company has received an Innovate Award for a prestigious £1.5M grant. Exploiting revolutionary work in the field of integrated, accelerated drug discovery in micro-droplets, Bactevo will progress its programmes [...]

By | January 29th, 2017|BioPharma & Healthcare, News, Pharmaceuticals, Press Releases|

Demonstration of Multi-Season Efficacy and Immunogenicity of Codagenix’s CodaVax Intranasal Influenza Vaccine

Farmingdale, New York, January 6, 2017 – Codagenix, Inc., a clinical stage, venture and public sector-funded small business, announced today data demonstrating multi-season efficacy for its intranasal Influenza A vaccine.  Multiple studies conducted in pigs and ferrets have shown that [...]

By | January 20th, 2017|BioPharma & Healthcare, News, Pharmaceuticals, Press Releases|

Synpromics announces a research collaboration with GE Healthcare to Extend the Toolbox for Production of Biologics

Edinburgh, UK, 4th January 2017 / Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce a research collaboration with GE Healthcare to jointly develop customised synthetic promoters optimised for GE Healthcare’s proprietary biopharmaceutical manufacturing platform. Synpromics will [...]

Amyris Enters Collaboration with Top 10 Pharmaceutical Company for Biosynthetic Drug Discovery

Amyris's Leading µPharm™ Platform Focused on Rapid Discovery of Novel Antibiotic Compound Target EMERYVILLE, Calif., Oct. 28, 2016 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, is pleased to announce it has entered into a research agreement with [...]

By | November 1st, 2016|BioPharma & Healthcare, News, Pharmaceuticals|